 | • レポートコード：MRC2012B0042 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、痔瘻治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。痔瘻治療の種類別市場規模（瘻孔切開術、シートン技術、フラップ手術、組織接着剤、バイオプロテーゼプラグ、その他新技術）、用途別市場規模（括約筋外瘻、括約筋上瘻、経括約筋瘻、括約筋間瘻、粘膜下瘻、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Teva、Aurobindo pharma、Johnson & Johnson、Novartis、Mylan、Pfizer、Boehringer Ingelheim、Aptalis Pharma、Roche、Bristol Myers、 ・地域別グローバル市場分析 2015年-2020年 ・痔瘻治療の北米市場（アメリカ、カナダ、メキシコ） ・痔瘻治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・痔瘻治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・痔瘻治療の南米市場（ブラジル、アルゼンチン） ・痔瘻治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：瘻孔切開術、シートン技術、フラップ手術、組織接着剤、バイオプロテーゼプラグ、その他新技術 ・用途別分析：括約筋外瘻、括約筋上瘻、経括約筋瘻、括約筋間瘻、粘膜下瘻、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Anal Fistula Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.3% in the forecast period of 2020 to 2025 and will expected to reach USD 556.1 million by 2025, from USD 508.2 million in 2019.
The Anal Fistula Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Anal Fistula Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Anal Fistula Treatment market has been segmented into:
Fistulotomy
Seton Techniques
Advancement Flap Procedures
Fibrin Glue
Bioprosthetic Plug
Other Emerging Techniques
By Application, Anal Fistula Treatment has been segmented into:
Extrasphincteric Fistula
Suprasphincteric Fistula
Transphincteric Fistula
Intersphincteric Fistula
Submucosal Fistula
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Anal Fistula Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Anal Fistula Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Anal Fistula Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Anal Fistula Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Anal Fistula Treatment Market Share Analysis
Anal Fistula Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Anal Fistula Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Anal Fistula Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Anal Fistula Treatment are:
Teva
Aurobindo pharma
Johnson & Johnson
Novartis
Mylan
Pfizer
Boehringer Ingelheim
Aptalis Pharma
Roche
Bristol Myers
Table of Contents
1 Anal Fistula Treatment Market Overview
1.1 Product Overview and Scope of Anal Fistula Treatment
1.2 Classification of Anal Fistula Treatment by Type
1.2.1 Global Anal Fistula Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Anal Fistula Treatment Revenue Market Share by Type in 2019
1.2.3 Fistulotomy
1.2.4 Seton Techniques
1.2.5 Advancement Flap Procedures
1.2.6 Fibrin Glue
1.2.7 Bioprosthetic Plug
1.2.8 Other Emerging Techniques
1.3 Global Anal Fistula Treatment Market by Application
1.3.1 Overview: Global Anal Fistula Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Extrasphincteric Fistula
1.3.3 Suprasphincteric Fistula
1.3.4 Transphincteric Fistula
1.3.5 Intersphincteric Fistula
1.3.6 Submucosal Fistula
1.3.7 Other
1.4 Global Anal Fistula Treatment Market by Regions
1.4.1 Global Anal Fistula Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Anal Fistula Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Anal Fistula Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Anal Fistula Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Anal Fistula Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Anal Fistula Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Anal Fistula Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Teva SWOT Analysis
2.1.4 Teva Product and Services
2.1.5 Teva Anal Fistula Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Aurobindo pharma
2.2.1 Aurobindo pharma Details
2.2.2 Aurobindo pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Aurobindo pharma SWOT Analysis
2.2.4 Aurobindo pharma Product and Services
2.2.5 Aurobindo pharma Anal Fistula Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Johnson & Johnson SWOT Analysis
2.3.4 Johnson & Johnson Product and Services
2.3.5 Johnson & Johnson Anal Fistula Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Anal Fistula Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Mylan SWOT Analysis
2.5.4 Mylan Product and Services
2.5.5 Mylan Anal Fistula Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer Anal Fistula Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Boehringer Ingelheim
2.7.1 Boehringer Ingelheim Details
2.7.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Boehringer Ingelheim SWOT Analysis
2.7.4 Boehringer Ingelheim Product and Services
2.7.5 Boehringer Ingelheim Anal Fistula Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Aptalis Pharma
2.8.1 Aptalis Pharma Details
2.8.2 Aptalis Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Aptalis Pharma SWOT Analysis
2.8.4 Aptalis Pharma Product and Services
2.8.5 Aptalis Pharma Anal Fistula Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Roche
2.9.1 Roche Details
2.9.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Roche SWOT Analysis
2.9.4 Roche Product and Services
2.9.5 Roche Anal Fistula Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bristol Myers
2.10.1 Bristol Myers Details
2.10.2 Bristol Myers Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bristol Myers SWOT Analysis
2.10.4 Bristol Myers Product and Services
2.10.5 Bristol Myers Anal Fistula Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Anal Fistula Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Anal Fistula Treatment Players Market Share
3.2.2 Top 10 Anal Fistula Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Anal Fistula Treatment Revenue and Market Share by Regions
4.2 North America Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
5 North America Anal Fistula Treatment Revenue by Countries
5.1 North America Anal Fistula Treatment Revenue by Countries (2015-2020)
5.2 USA Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
6 Europe Anal Fistula Treatment Revenue by Countries
6.1 Europe Anal Fistula Treatment Revenue by Countries (2015-2020)
6.2 Germany Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
6.4 France Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Anal Fistula Treatment Revenue by Countries
7.1 Asia-Pacific Anal Fistula Treatment Revenue by Countries (2015-2020)
7.2 China Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
7.5 India Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
8 South America Anal Fistula Treatment Revenue by Countries
8.1 South America Anal Fistula Treatment Revenue by Countries (2015-2020)
8.2 Brazil Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Anal Fistula Treatment by Countries
9.1 Middle East & Africa Anal Fistula Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Anal Fistula Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Anal Fistula Treatment Market Forecast by Type (2019-2024)
10.3 Fistulotomy Revenue Growth Rate (2015-2025)
10.4 Seton Techniques Revenue Growth Rate (2015-2025)
10.5 Advancement Flap Procedures Revenue Growth Rate (2015-2025)
10.6 Fibrin Glue Revenue Growth Rate (2015-2025)
10.7 Bioprosthetic Plug Revenue Growth Rate (2015-2025)
10.8 Other Emerging Techniques Revenue Growth Rate (2015-2025)
11 Global Anal Fistula Treatment Market Segment by Application
11.1 Global Anal Fistula Treatment Revenue Market Share by Application (2015-2020)
11.2 Anal Fistula Treatment Market Forecast by Application (2019-2024)
11.3 Extrasphincteric Fistula Revenue Growth (2015-2020)
11.4 Suprasphincteric Fistula Revenue Growth (2015-2020)
11.5 Transphincteric Fistula Revenue Growth (2015-2020)
11.6 Intersphincteric Fistula Revenue Growth (2015-2020)
11.7 Submucosal Fistula Revenue Growth (2015-2020)
11.8 Other Revenue Growth (2015-2020)
12 Global Anal Fistula Treatment Market Size Forecast (2021-2025)
12.1 Global Anal Fistula Treatment Market Size Forecast (2021-2025)
12.2 Global Anal Fistula Treatment Market Forecast by Regions (2021-2025)
12.3 North America Anal Fistula Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Anal Fistula Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Anal Fistula Treatment Revenue Market Forecast (2021-2025)
12.6 South America Anal Fistula Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Anal Fistula Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Anal Fistula Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Anal Fistula Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Anal Fistula Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Anal Fistula Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Teva Corporate Information, Location and Competitors
Table 6. Teva Anal Fistula Treatment Major Business
Table 7. Teva Anal Fistula Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Teva SWOT Analysis
Table 9. Teva Anal Fistula Treatment Product and Solutions
Table 10. Teva Anal Fistula Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Aurobindo pharma Corporate Information, Location and Competitors
Table 12. Aurobindo pharma Anal Fistula Treatment Major Business
Table 13. Aurobindo pharma Anal Fistula Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Aurobindo pharma SWOT Analysis
Table 15. Aurobindo pharma Anal Fistula Treatment Product and Solutions
Table 16. Aurobindo pharma Anal Fistula Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Johnson & Johnson Corporate Information, Location and Competitors
Table 18. Johnson & Johnson Anal Fistula Treatment Major Business
Table 19. Johnson & Johnson Anal Fistula Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Johnson & Johnson SWOT Analysis
Table 21. Johnson & Johnson Anal Fistula Treatment Product and Solutions
Table 22. Johnson & Johnson Anal Fistula Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Novartis Corporate Information, Location and Competitors
Table 24. Novartis Anal Fistula Treatment Major Business
Table 25. Novartis Anal Fistula Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Novartis SWOT Analysis
Table 27. Novartis Anal Fistula Treatment Product and Solutions
Table 28. Novartis Anal Fistula Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Mylan Corporate Information, Location and Competitors
Table 30. Mylan Anal Fistula Treatment Major Business
Table 31. Mylan Anal Fistula Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Mylan SWOT Analysis
Table 33. Mylan Anal Fistula Treatment Product and Solutions
Table 34. Mylan Anal Fistula Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Pfizer Corporate Information, Location and Competitors
Table 36. Pfizer Anal Fistula Treatment Major Business
Table 37. Pfizer Anal Fistula Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Pfizer SWOT Analysis
Table 39. Pfizer Anal Fistula Treatment Product and Solutions
Table 40. Pfizer Anal Fistula Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 42. Boehringer Ingelheim Anal Fistula Treatment Major Business
Table 43. Boehringer Ingelheim Anal Fistula Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Boehringer Ingelheim SWOT Analysis
Table 45. Boehringer Ingelheim Anal Fistula Treatment Product and Solutions
Table 46. Boehringer Ingelheim Anal Fistula Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Aptalis Pharma Corporate Information, Location and Competitors
Table 48. Aptalis Pharma Anal Fistula Treatment Major Business
Table 49. Aptalis Pharma Anal Fistula Treatment Total Revenue (USD Million) (2017-2018)
Table 50. Aptalis Pharma SWOT Analysis
Table 51. Aptalis Pharma Anal Fistula Treatment Product and Solutions
Table 52. Aptalis Pharma Anal Fistula Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Roche Corporate Information, Location and Competitors
Table 54. Roche Anal Fistula Treatment Major Business
Table 55. Roche Anal Fistula Treatment Total Revenue (USD Million) (2017-2018)
Table 56. Roche SWOT Analysis
Table 57. Roche Anal Fistula Treatment Product and Solutions
Table 58. Roche Anal Fistula Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Bristol Myers Corporate Information, Location and Competitors
Table 60. Bristol Myers Anal Fistula Treatment Major Business
Table 61. Bristol Myers Anal Fistula Treatment Total Revenue (USD Million) (2017-2018)
Table 62. Bristol Myers SWOT Analysis
Table 63. Bristol Myers Anal Fistula Treatment Product and Solutions
Table 64. Bristol Myers Anal Fistula Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Anal Fistula Treatment Revenue (Million USD) by Players (2015-2020)
Table 66. Global Anal Fistula Treatment Revenue Share by Players (2015-2020)
Table 67. Global Anal Fistula Treatment Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Anal Fistula Treatment Revenue Market Share by Regions (2015-2020)
Table 69. North America Anal Fistula Treatment Revenue by Countries (2015-2020)
Table 70. North America Anal Fistula Treatment Revenue Market Share by Countries (2015-2020)
Table 71. Europe Anal Fistula Treatment Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Anal Fistula Treatment Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Anal Fistula Treatment Revenue by Countries (2015-2020)
Table 74. South America Anal Fistula Treatment Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Anal Fistula Treatment Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Anal Fistula Treatment Revenue Market Share by Countries (2015-2020)
Table 77. Global Anal Fistula Treatment Revenue (Million USD) by Type (2015-2020)
Table 78. Global Anal Fistula Treatment Revenue Share by Type (2015-2020)
Table 79. Global Anal Fistula Treatment Revenue Forecast by Type (2021-2025)
Table 80. Global Anal Fistula Treatment Revenue by Application (2015-2020)
Table 81. Global Anal Fistula Treatment Revenue Share by Application (2015-2020)
Table 82. Global Anal Fistula Treatment Revenue Forecast by Application (2021-2025)
Table 83. Global Anal Fistula Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Anal Fistula Treatment Picture
Figure 2. Global Anal Fistula Treatment Revenue Market Share by Type in 2019
Figure 3. Fistulotomy Picture
Figure 4. Seton Techniques Picture
Figure 5. Advancement Flap Procedures Picture
Figure 6. Fibrin Glue Picture
Figure 7. Bioprosthetic Plug Picture
Figure 8. Other Emerging Techniques Picture
Figure 9. Anal Fistula Treatment Revenue Market Share by Application in 2019
Figure 10. Extrasphincteric Fistula Picture
Figure 11. Suprasphincteric Fistula Picture
Figure 12. Transphincteric Fistula Picture
Figure 13. Intersphincteric Fistula Picture
Figure 14. Submucosal Fistula Picture
Figure 15. Other Picture
Figure 16. Global Anal Fistula Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 17. North America Anal Fistula Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Europe Anal Fistula Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Asia-Pacific Anal Fistula Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. South America Anal Fistula Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Middle East and Africa Anal Fistula Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Anal Fistula Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. Global Anal Fistula Treatment Revenue Share by Players in 2019
Figure 24. Global Top 5 Players Anal Fistula Treatment Revenue Market Share in 2019
Figure 25. Global Top 10 Players Anal Fistula Treatment Revenue Market Share in 2019
Figure 26. Key Players Market Share Trend
Figure 27. Global Anal Fistula Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 28. Global Anal Fistula Treatment Revenue Market Share by Regions (2015-2020)
Figure 29. Global Anal Fistula Treatment Revenue Market Share by Regions in 2018
Figure 30. North America Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Europe Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Asia-Pacific Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
Figure 33. South America Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Middle East and Africa Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
Figure 35. North America Anal Fistula Treatment Revenue Market Share by Countries (2015-2020)
Figure 36. North America Anal Fistula Treatment Revenue Market Share by Countries in 2019
Figure 37. USA Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
Figure 38. Canada Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Mexico Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Europe Anal Fistula Treatment Revenue Market Share by Countries (2015-2020)
Figure 41. Europe Anal Fistula Treatment Revenue Market Share by Countries in 2019
Figure 42. Germany Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
Figure 43. UK Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
Figure 44. France Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Russia Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Italy Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Anal Fistula Treatment Revenue Market Share by Countries (2015-2020)
Figure 48. Asia-Pacific Anal Fistula Treatment Revenue Market Share by Countries in 2019
Figure 49. China Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Japan Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
Figure 51. Korea Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
Figure 52. India Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
Figure 53. Southeast Asia Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
Figure 54. South America Anal Fistula Treatment Revenue Market Share by Countries (2015-2020)
Figure 55. South America Anal Fistula Treatment Revenue Market Share by Countries in 2019
Figure 56. Brazil Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Argentina Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
Figure 58. Middle East and Africa Anal Fistula Treatment Revenue Market Share by Countries (2015-2020)
Figure 59. Middle East and Africa Anal Fistula Treatment Revenue Market Share by Countries in 2019
Figure 60. Saudi Arabia Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
Figure 61. UAE Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
Figure 62. Egypt Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
Figure 63. South Africa Anal Fistula Treatment Revenue and Growth Rate (2015-2020)
Figure 64. Global Anal Fistula Treatment Revenue Share by Type (2015-2020)
Figure 65. Global Anal Fistula Treatment Revenue Share by Type in 2019
Figure 66. Global Anal Fistula Treatment Market Share Forecast by Type (2021-2025)
Figure 67. Global Fistulotomy Revenue Growth Rate (2015-2020)
Figure 68. Global Seton Techniques Revenue Growth Rate (2015-2020)
Figure 69. Global Advancement Flap Procedures Revenue Growth Rate (2015-2020)
Figure 70. Global Fibrin Glue Revenue Growth Rate (2015-2020)
Figure 71. Global Bioprosthetic Plug Revenue Growth Rate (2015-2020)
Figure 72. Global Other Emerging Techniques Revenue Growth Rate (2015-2020)
Figure 73. Global Anal Fistula Treatment Revenue Share by Application (2015-2020)
Figure 74. Global Anal Fistula Treatment Revenue Share by Application in 2019
Figure 75. Global Anal Fistula Treatment Market Share Forecast by Application (2021-2025)
Figure 76. Global Extrasphincteric Fistula Revenue Growth Rate (2015-2020)
Figure 77. Global Suprasphincteric Fistula Revenue Growth Rate (2015-2020)
Figure 78. Global Transphincteric Fistula Revenue Growth Rate (2015-2020)
Figure 79. Global Intersphincteric Fistula Revenue Growth Rate (2015-2020)
Figure 80. Global Submucosal Fistula Revenue Growth Rate (2015-2020)
Figure 81. Global Other Revenue Growth Rate (2015-2020)
Figure 82. Global Anal Fistula Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 83. Global Anal Fistula Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 84. Global Anal Fistula Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 85. North America Anal Fistula Treatment Revenue Market Forecast (2021-2025)
Figure 86. Europe Anal Fistula Treatment Revenue Market Forecast (2021-2025)
Figure 87. Asia-Pacific Anal Fistula Treatment Revenue Market Forecast (2021-2025)
Figure 88. South America Anal Fistula Treatment Revenue Market Forecast (2021-2025)
Figure 89. Middle East and Africa Anal Fistula Treatment Revenue Market Forecast (2021-2025)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
肛門癌・結腸直腸癌の世界市場（～2026年） Colorectal cancer is a malignant tumor that starts in the cells of the colon or the rectum while it takes place in anus in case of anal cancer. Rising prevalence of anal and colorectal cancer due to poor lifestyles such as obesity and tobacco consumption has been the major factor driving the market …- 子宮筋腫治療装置の世界市場（～2026年） Uterine fibroids are noncancerous growths of the uterus that often appear during childbearing years. Also called leiomyomas (lie-o-my-O-muhs) or myomas, uterine fibroids aren't associated with an increased risk of uterine cancer and almost never develop into cancer. Market Analysis and Insights: Glo…
- 軟骨無形成症治療の世界市場（～2026年） Market Analysis and Insights: Global Achondroplasia Treatment Market The global Achondroplasia Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Achondroplasia Treatment Scope and Market Size Achondroplasia Tre…
- クラッベ病治療の世界市場（～2026年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…
- 交流電場腫瘍治療の世界市場（～2026年） Alternating electric field tumor therapy is an anticancer treatment which disrupts the tumor cells mitosis. Alternating electric field therapy is a low intensity technique which disrupts the division of cells through physical interaction of molecules during mitosis in tumor cancer. The alternating e…